Related Experiment Videos
The morphine hydrogel suppository. A new sustained release rectal preparation
C D Hanning1, A P Vickers, G Smith
1University Department of Anaesthesia, Leicester Royal Infirmary.
British Journal of Anaesthesia
|August 1, 1988
Summary
Morphine hydrogel suppositories (MHS) offer sustained pain relief. Pilot studies indicate MHS may effectively manage postoperative pain through tailored release profiles.
Area of Science:
- Pharmacology
- Drug Delivery Systems
- Pain Management
Background:
- Postoperative pain management remains a clinical challenge.
- Sustained-release drug delivery aims to improve therapeutic efficacy and patient compliance.
- Rectal administration offers an alternative route for drug delivery.
Purpose of the Study:
- To develop and evaluate a novel morphine hydrogel suppository (MHS) for sustained drug release.
- To assess two distinct release profiles, MHS(B) and MHS(S), for managing morphine plasma concentrations.
- To determine the potential of MHS in alleviating postoperative pain.
Main Methods:
- Development of a monolithic sustained-release rectal preparation (MHS).
- Preparation of two release profiles: MHS(B) (high initial, then constant release) and MHS(S) (constant release).
- Evaluation of MHS through three pilot studies.
Main Results:
- MHS(B) designed for rapid attainment and maintenance of analgesic morphine concentrations.
- MHS(S) designed for maintaining therapeutic concentrations over successive 12-h periods.
- Pilot studies demonstrated the feasibility and potential efficacy of MHS.
Conclusions:
- Morphine hydrogel suppositories (MHS) represent a promising sustained-release rectal formulation.
- MHS may offer a valuable therapeutic option for managing postoperative pain.
- Further clinical evaluation is warranted to confirm the efficacy and safety of MHS.